Ophthalmology · Hacienda Heights, CA
NPI
1043276140
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1850 S Azusa Ave, Ste 107
Hacienda Heights, CA, 91745
Phone (626) 912-6888
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
12,300 services
Medicare patients, 2024
1,760
Average age 77
Drug cost, 2024
$2.9M
17,871 prescriptions
Company payments, 2025
$1,790
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Garlan G Lo was code 92136 (ultrasound - nonspecific), 2,068 times for 598 patients. In total Garlan G Lo billed 12,300 services in 45 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92136 Ultrasound - Nonspecific | Office | 2,068 | 598 | $20.46 | $42K |
| 92014 Ophthalmological E&M | Office | 1,926 | 1,351 | $89.80 | $173K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,533 | 1,086 | $30.45 | $47K |
| 92012 Ophthalmological E&M | Office | 1,385 | 743 | $69.03 | $96K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,209 | 1,067 | $49.60 | $60K |
| 92250 Angiography | Office | 1,159 | 1,053 | $27.32 | $32K |
| 92133 Computerized Ophthalmic Imaging | Office | 586 | 555 | $26.71 | $16K |
| 67028 Intravitreal Injection | Office | 469 | 105 | $112.64 | $53K |
| J9035 Injection, bevacizumab, 10 mg | Office | 468 | 82 | $57.43 | $27K |
| J0178 Injection, aflibercept, 1 mg | Office | 384 | 32 | $658.07 | $253K |
| 92004 Ophthalmological E&M | Office | 345 | 345 | $105.24 | $36K |
| 66984 Cataract Surgery | Facility | 185 | 148 | $423.41 | $78K |
| 66821 Cataract Surgery | Office | 68 | 61 | $288.42 | $20K |
| 92132 Computerized Ophthalmic Imaging | Office | 29 | 29 | $25.89 | $751 |
| 67820 Eye | Office | 25 | 20 | $13.96 | $349 |
By year: 2022 $1.0M for 14,138 services; 2023 $1.2M for 14,837 services; 2024 $1.0M for 12,300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Garlan G Lo prescribed most often to Medicare patients was Azelastine Hcl, with 4,036 prescriptions and refills. In total Garlan G Lo wrote 17,871 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 4,036 | 5,597 | 1,307 | $73K |
| Latanoprost Generic | 3,343 | 5,947 | 771 | $41K |
| Erythromycin Erythromycin Base | 1,113 | 1,147 | 425 | $12K |
| Timolol Maleate Generic | 1,112 | 2,275 | 273 | $17K |
| Cyclosporine Generic | 1,106 | 2,120 | 395 | $638K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,089 | 2,212 | 271 | $22K |
| Restasis Cyclosporine | 1,007 | 1,496 | 319 | $919K |
| Prednisolone Acetate Generic | 664 | 775 | 436 | $31K |
| Brimonidine Tartrate Generic | 620 | 1,142 | 156 | $38K |
| Lumigan Bimatoprost | 525 | 737 | 116 | $222K |
| Moxifloxacin Moxifloxacin Hcl | 464 | 465 | 346 | $17K |
| Fluorometholone Generic | 212 | 261 | 108 | $24K |
| Ciprofloxacin Hcl Generic | 200 | 201 | 142 | $2,798 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 195 | 196 | 122 | $1,818 |
| Xiidra Lifitegrast | 184 | 303 | 64 | $201K |
Brand drugs: - claims; generic drugs: 11,763 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Garlan G Lo $1,790 ($1,790 in general payments such as food, travel and fees) from 16 companies. The largest payer was Alcon Vision LLC with $314.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 9 | $314 |
| Abbvie Inc. ABBV | 12 | $225 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $170 |
| Bausch & Lomb Americas Inc. BLCO | 9 | $167 |
| Amgen Inc. AMGN | 6 | $165 |
| Oyster Point Pharma, Inc. | 6 | $146 |
| Dompe US, Inc. | 4 | $109 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $88.36 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $69.52 |
| Harrow Eye, LLC | 2 | $66.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.